Literature DB >> 18681197

Health care knowledge and consumer learning: the case of direct-to-consumer drug advertising.

Marjorie Delbaere1, Malcolm C Smith.   

Abstract

This research develops a framework for understanding how consumers process health-related information and interact with their caregivers. The context is direct-to-consumer (DTC) advertising by pharmaceutical companies in North America. This theoretical research presents a research framework and focuses on the presentation of information in advertisements, consumer-learning processes, consumer utilization of health care knowledge, and bias in perceived risk. The paper proposes that consumers who lack expertise with prescription drugs learn from DTC ads differently than those with expertise. Further, it is proposed that consumers also process the information in DTC ads differently depending on the perceived effectiveness of the drug being advertised, and ultimately utilize the knowledge taken from the ads in many different ways, some of which may appear irrational to health care providers. By understanding how consumers interpret and learn from DTC ads, health care organizations and providers may be able to improve health care delivery and consumer outcomes.

Mesh:

Year:  2006        PMID: 18681197     DOI: 10.1080/07359680802086059

Source DB:  PubMed          Journal:  Health Mark Q        ISSN: 0735-9683


  4 in total

1.  Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic?

Authors:  C Lee Ventola
Journal:  P T       Date:  2011-10

2.  Evaluation of Selective Outcome Reporting Bias in Efficacy Endpoints in Print and Television Advertisements for Oncology Drugs.

Authors:  Cole Wayant; Greg Aran; Bradley S Johnson; Matt Vassar
Journal:  J Gen Intern Med       Date:  2020-07-13       Impact factor: 5.128

3.  Trends in exposure to televised prescription drug advertising, 2003-2011.

Authors:  Rachel Kornfield; G Caleb Alexander; Dima M Qato; Yoonsang Kim; Jan D Hirsch; Sherry L Emery
Journal:  Am J Prev Med       Date:  2015-05       Impact factor: 5.043

4.  'At-risk' individuals' responses to direct to consumer advertising of prescription drugs: a nationally representative cross-sectional study.

Authors:  Neda Khalil Zadeh; Kirsten Robertson; James A Green
Journal:  BMJ Open       Date:  2017-12-06       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.